New Delhi | December 4th, 2025: Shardul Amarchand Mangaldas & Co. (SAM) acted as the legal advisor to Eris Lifesciences Limited (“ELL”) in connection with its proposed acquisition of 30% of the total share capital of Swiss Parenterals Limited (“SPL”) (in which ELL currently holds 70% of the share capital) from Mr. Naishadh Shah (Director, SPL), for an aggregate consideration of INR 423.30 crores. The consideration will be discharged by ELL by way of issuance of equity shares of ELL to Mr. Naishadh Shah, on a preferential basis.
Upon completion of the proposed acquisition, subject to receipt of necessary stock exchange approvals, SPL will become a wholly owned subsidiary of ELL.
The SAM transaction team was led by Nivedita Tiwari, Partner, and Devesh Pandey, Partner, along with Kuhuk Jain, Principal Associate; Anushka Ganguli, Associate; and Sourav Paul, Associate.
Gouri Puri, Partner, Rahul Yadav, Partner and Nimish Malpani, Principal Associate advised ELL on the tax related aspects pertaining to the transaction.